A federal appeals court on Tuesday appeared open to claims that the FDA failed to go through notice-and-comment procedures when it ordered companies seeking to market flavored e-cigarettes to provide data showing their products had benefits over tobacco-flavored products.
The US Food and Drug Administration denied “millions” of applications from companies seeking to market flavored vaping products because sellers didn’t know they were obliged to “have this comparison to show the demonstration of appropriateness,” Judge
Judge
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.